FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review

18F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used for response evaluation in metastatic breast cancer (MBC). In this study, we aimed to review literature comparing the PET Response Criteria...

Full description

Bibliographic Details
Main Authors: Fredrik Helland, Martine Hallin Henriksen, Oke Gerke, Marianne Vogsen, Poul Flemming Høilund-Carlsen, Malene Grubbe Hildebrandt
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Diagnostics
Subjects:
FDG-PET/CT
PERCIST
CE-CT
RECIST
response evaluation
metastatic breast cancer
Online Access:https://www.mdpi.com/2075-4418/9/3/106

Internet

https://www.mdpi.com/2075-4418/9/3/106

Similar Items